Timothy M. Ring serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Ring has been a member of the board since 2017, previously serving as chairman and chief executive officer of C. R. Bard, Inc. from 2003 to 2017.
Ring also is lead director of Quest Diagnostics Incorporated, and a co-founder of TEAMFund, Inc., an impact fund focused on delivering medical technology to sub-Saharan Africa and India.
With over 20 years of experience in various leadership positions at Bard, Ring offers a unique perspective on the Bard business. As an experienced chief executive officer of a public company, Ring also contributes expertise in many facets of business, including strategy, product development and international operations, and has extensive experience in the healthcare industry.